Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients
Authors:
Open Access
- 16 February 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 17 (7) , 1068.1-1075
Abstract
In patients with an implantable cardioverter-defibrillator (ICD), ICD shocks due to ventricular tachycardia (VT) or ventricular fibrillation (VF) have been associated with an increased mortality. It is not known whether patients with antitachycardia pacing (ATP)-terminated VT/VF episodes have a similar worse outcome. The aim of this study was to evaluate the clinical course and prognostic impact of ATP-terminated episodes on mortality in ICD patients. A total of 1398 consecutive patients of the prospective single-centre ICD-registry Ludwigshafen who underwent an ICD implantation between 1992 and 2008 for primary or secondary prevention of sudden cardiac death were analysed. Patients treated with ATP were compared with patients with appropriate ICD shocks or patients without any appropriate ATP or ICD shock. During the median follow-up time of 6 years, 749 (54%) patients experienced 17 827 episodes of VT or VF which were terminated by ATP in 74% and by shock in 26% of patients. In approximately half (n = 321/749) of those patients with VT/VF, the first episode was terminated by ATP. In a multivariate analysis adjusted for different baseline confounding parameters, the occurrence of first ATP therapy was associated with a higher mortality rate [hazard ratio (HR) 2.60, 95% confidence interval (CI) 2.02–3.35]. When excluding all patients with appropriate ICD shocks first ATP therapy remained associated with a worse prognosis (HR 1.92, 95% CI 1.38–2.67). In ICD patients, about three-fourths of ventricular arrhythmias are terminated by ATP. The occurrence of ATP-terminated episode is associated with an increased mortality rate.Keywords
This publication has 21 references indexed in Scilit:
- Examination of the differential impacts of antitachycardia pacing vs. shock on patient activity in the EMPIRIC studyEP Europace, 2015
- The Association Between ICD Interventions and Mortality is Independent of their Modality: Clinical ImplicationsJournal of Cardiovascular Electrophysiology, 2014
- Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: A meta-analysisHeart Rhythm, 2014
- Reduction in Inappropriate Therapy and Mortality through ICD ProgrammingNew England Journal of Medicine, 2012
- Comparison Between Atrial Fibrillation‐Triggered Implantable Cardioverter‐Defibrillator (ICD) Shocks and Inappropriate Shocks Caused by Lead Failure: Different Impact on Prognosis in Clinical PracticeJournal of Cardiovascular Electrophysiology, 2012
- Prognostic Importance of Defibrillator Shocks in Patients with Heart FailureNew England Journal of Medicine, 2008
- Quality of Life with Defibrillator Therapy or Amiodarone in Heart FailureNew England Journal of Medicine, 2008
- Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted DefibrillatorCirculation, 2004
- Prevention of Implantable-Defibrillator Shocks by Treatment with SotalolNew England Journal of Medicine, 1999
- A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular ArrhythmiasNew England Journal of Medicine, 1997